Trial intelligence / Profile preview

Muscle strength and mass after bariatric surgery – effect of testosterone replacement therapy

2024-517015-73-00Phase 4Completed

Sponsor
Hospital of South West Jutland
Start
Sep 2024
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in obesity and Hypoandrogenism (TD) comparing Nebido with Placebo oily solution (2 arms). Primary endpoint: Maximal isometric muscle strength in shoulder muscles (shoulder elevation). Started Sep 2024; status: completed.

02

Drugs

testosterone undecanoate
03

Conditions

obesityHypoandrogenism (TD)

Beyond the preview

Go deeper on 2024-517015-73-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-517015-73-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call